In the field of medical injection molding, the application of mold release agents directly affects product qualification rates, mold service life, and patient safety. Due to the extremely high requirements for surface finish, biocompatibility, and cleanliness of medical products, traditional industrial mold release solutions are difficult to meet the needs. This article systematically elaborates on the selection criteria, usage processes, and quality control points of mold release agents in combination with the characteristics of the medical industry.

I. Special Requirements for Mold Release Agents in Medical Injection Molding

1. Biological Safety: They need to pass the ISO 10993 biocompatibility test to ensure no cytotoxicity and no sensitization reactions. For example, silicone-based mold release agents should use medical-grade raw materials to avoid heavy metal impurities in ordinary industrial-grade products.
2. Low Residue: The components of mold release agents should comply with the FDA 21 CFR 175.300 standard, and the residue amount should be controlled at the ppm level. A cardiac stent manufacturer reduced the surface residue of products from 0.8 mg/cm² to 0.1 mg/cm² by using a water-based mold release agent.
3. High-temperature Resistance: Common engineering plastics in medical injection molding, such as PPSU and PEEK, have processing temperatures of 300 - 400°C, requiring the thermal decomposition temperature of mold release agents to be ≥ 450°C. A manufacturer of orthopedic implants selected a fluoropolymer mold release agent, which maintained stable mold release performance for 2000 mold cycles at 380°C.
4. Antistatic Property: To prevent tiny medical components (such as stethoscope earplugs) from adsorbing dust due to static electricity, it is necessary to choose a special formula with added antistatic agents.

II. Scientific Usage Process

1. Mold Pre-treatment Stage

• Deep Cleaning: Adopt a three-step cleaning method for new molds:
  1. Mechanical polishing: Use 600-mesh sandpaper to remove machining marks.
  2. Solvent cleaning: Ultrasonic cleaning with isopropyl alcohol for 15 minutes.
  3. Plasma treatment: Oxygen plasma treatment for 10 minutes to activate the mold surface.
• Pore Sealing Treatment: For porous molds (such as powder metallurgy molds), conduct nano-scale pore sealing:
  • Use a pore-sealing agent containing nano-silica, apply 2 layers with an interval of 30 minutes between each layer.
  • Test standard: Adhesive force of masking tape ≤ 0.2 N/cm².

2. Mold Release Agent Coating Process

• Coating Method Optimization:
  • For precision components: Use electrostatic spraying technology, with a coating utilization rate of up to 92%.
  • For complex cavities: Use a robotic arm for programmed spraying to ensure a uniform film thickness of ±5% in the corners.
• Layered Coating Technology:
  • Base layer: Water-based mold release agent, with a film thickness of 3 - 5 μm.
  • Functional layer: Fluoropolymer mold release agent, with a film thickness of 1 - 2 μm.
  • Drying interval: Dry with 80°C hot air for 10 minutes between each layer.

3. Production Process Control

• First Mold Release Management:
  • Conduct surface residue detection (GC-MS analysis) on the first product.
  • Use a progressive mold release pressure for the first 50 mold cycles (gradually increase from 50 bar to 120 bar).
• Online Monitoring System:
  • Install a film thickness monitor to provide real-time feedback on the coating thickness.
  • Connect to the MES system to automatically record the amount of mold release agent used for each mold cycle.

III. Typical Application Case Analysis

Case 1: Production of Insulin Pen Needle Seats

• Material: POM (polyoxymethylene)
• Challenge: The product has a wall thickness of 0.3 mm and is prone to tearing during mold release.
• Solution:
  1. Select a wax-based mold release agent containing polytetrafluoroethylene micropowder.
  2. Use the "sandwich coating method": base layer of wax agent + intermediate layer of silicone oil + surface layer of antistatic agent.
  3. Effect: The mold release force decreased from 120 N to 45 N, and the product qualification rate increased from 82% to 98%.

Case 2: Maintenance of Orthopedic Implant Molds

• Material: PEEK (polyether ether ketone)
• Challenge: The mold cavity has a depth of 150 mm, and traditional mold release agents are prone to accumulation.
• Solution:
  1. Customize a low-viscosity (50 mPa·s) mold release agent.
  2. Implement pulsed spraying: 0.2 seconds of spraying + 0.5 seconds of interval.
  3. Effect: The mold cleaning cycle was extended from every 500 mold cycles to 3000 mold cycles.

IV. Construction of a Quality Control System

1. Incoming Inspection:
   • Detect component consistency using infrared spectroscopy.
   • Detect viscosity fluctuations using a rotational viscometer (control range ±5%).
2. Process Control:
   • Establish a model of the relationship between the amount of mold release agent used and product dimensional changes.
   • Implement SPC control charts to monitor the stability of film thickness.
3. Finished Product Inspection:
   • Use a surface roughness tester to detect the Ra value (medical-grade requirement ≤ 0.1 μm).
   • Use ion chromatography to detect extractable metal ions (limit value ≤ 5 ppm).

V. Future Development Trends

1. Intelligent Mold Release Systems: Integrated AI algorithm automatic spraying equipment can adjust spraying parameters in real-time.
2. Nano-modified Technology: Graphene-modified mold release agents can reduce the friction coefficient to 0.02.
3. Biodegradable Mold Release Agents: Environmentally friendly products based on polylactic acid meet the requirements of the EU REACH regulation.

In the field of medical injection molding, the application of mold release agents has evolved from a simple auxiliary tool to a core process factor affecting product quality. By establishing scientific selection criteria, refined usage processes, and strict quality control systems, the production efficiency and clinical safety of medical products can be significantly improved. With the development of material science and intelligent manufacturing technology, mold release agent technology will continue to drive the medical injection molding industry towards higher precision and more environmentally friendly directions.